TLDR:
Wobble Genomics, a UK-based company providing a novel approach to RNA sequencing, raised £8.5M in funding led by Mercia Ventures and BGF. The company aims to commercialize its technology specializing in optimizing RNA and DNA sequencing efficiency for various applications.
Article Summary:
Wobble Genomics, a University of Edinburgh spin-out, raised £8.5M in funding led by Mercia Ventures and BGF. The company specializes in optimizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers with wide-ranging applications. The funding round, which brought the total amount raised to $10.5M, was also backed by IQ Capital, EOS Advisors, and Old College Capital. The company, led by CEO Richard Kuo, plans to double its team size within the next two years. With genetic sequencing advancing towards long-read sequencing, Wobble Genomics’ solution is expected to accelerate biotechnology innovations. The funding will support the company’s mission to reveal the unseen world of RNA and unlock new applications in the field.
